Indomethacin induced toxic hepatitis: a case report
Turkish Journal of Internal Medicine · 2022
DOI: 10.46310/tjim.1072846 ↗At a glance
Fallbericht in Turkish Journal of Internal Medicine, 2022. Written by Orkun SAKAR and 3 co-authors. Cited 1 times so far (Crossref); 15 references. Funded by: Bursa Uludag University Faculty of Medicine.
Abstract (original language)
Nonsteroidal anti-inflammatory drugs deare widely used worldwide for analgesic, antipyretic and anti-inflammatory purposes. Indomethacin is a potent nonsteroidal anti-inflammatory drug and can cause severe liver damage. Few cases of idiosyncratic toxic hepatitis have been reported. Here, we present a case of indomethacin-induced toxic hepatitis that improved with methylprednisolone treatment.
Funding
- Bursa Uludag University Faculty of Medicine
Cite
APA
SAKAR, O., TEKER, T., NAK, S. G., & UĞRAŞ, N. (2022). Indomethacin induced toxic hepatitis: a case report. Turkish Journal of Internal Medicine. https://doi.org/10.46310/tjim.1072846
Vancouver
SAKAR O, TEKER T, NAK SG, UĞRAŞ N. Indomethacin induced toxic hepatitis: a case report. Turkish Journal of Internal Medicine. 2022. doi:10.46310/tjim.1072846
BibTeX
@article{SAKAR2022,
author = {SAKAR, Orkun and TEKER, Tufan and NAK, Selim Giray and UĞRAŞ, Nesrin},
title = {Indomethacin induced toxic hepatitis: a case report},
journal = {Turkish Journal of Internal Medicine},
year = {2022},
doi = {10.46310/tjim.1072846}
}
EUVIMED